Can Hyoscine Be Given in the First Trimester of Pregnancy?
Hyoscine (scopolamine/hyoscine butylbromide) is not recommended as a first-line treatment in the first trimester of pregnancy, particularly for nausea and vomiting, as it lacks safety and efficacy data for this indication and is not included in evidence-based guidelines for first trimester use.
Evidence-Based Reasoning
Guideline Recommendations for First Trimester
The most recent BJOG guideline (2024) on managing nausea and vomiting in pregnancy specifically identifies safe first-line antiemetics for the first trimester 1:
- First-line agents with safety data: Antihistamines (H1), phenothiazines, and doxylamine/pyridoxine
- Second-line agents: Ondansetron and metoclopramide
Notably, hyoscine is completely absent from these recommendations, indicating it is not considered an appropriate antiemetic for first trimester use 1.
Available Research Context
The research evidence for hyoscine focuses exclusively on:
- Labor management (cervical ripening and shortening labor duration) 2, 3, 4, 5
- Second trimester pregnancy termination for analgesia 6
- Non-pregnancy indications (IBS, procedural pain) 7, 8
No studies address hyoscine safety or efficacy in the first trimester for any indication.
Critical Safety Gaps
The FDA drug label 9 provides only packaging information for the transdermal formulation without pregnancy-specific safety data. The absence of:
- Teratogenicity data in first trimester
- Pharmacokinetic studies in early pregnancy
- Inclusion in authoritative pregnancy guidelines
...makes this an evidence-free zone for first trimester use.
Clinical Algorithm
For first trimester symptoms requiring treatment:
- Nausea/vomiting: Use guideline-recommended agents (antihistamines, phenothiazines, doxylamine/pyridoxine) 1
- Abdominal cramping/spasm: Consider non-pharmacologic measures first; if medication needed, consult obstetrics for appropriate alternatives
- Avoid hyoscine due to lack of safety data and guideline support
Common Pitfalls
- Do not extrapolate labor/second trimester data to first trimester safety
- Do not assume anticholinergic drugs are interchangeable in pregnancy—each requires specific safety evidence
- Recognize that hyoscine's anticholinergic effects can cause central nervous system complications including agitation and delirium 10, which may be particularly concerning in pregnancy